Patterns of Left Ventricular Remodelling in Children and Young Patients with Hypertrophic Cardiomyopathy
-
Published:2024-07-04
Issue:13
Volume:13
Page:3937
-
ISSN:2077-0383
-
Container-title:Journal of Clinical Medicine
-
language:en
-
Short-container-title:JCM
Author:
Monda Emanuele1ORCID, Caiazza Martina1ORCID, Cirillo Chiara1, Rubino Marta1, Verrillo Federica1, Palmiero Giuseppe1ORCID, Diana Gaetano1, Cirillo Annapaola1, Fusco Adelaide1, Guarnaccia Natale1, Buono Pietro2, Frisso Giulia3ORCID, Calabrò Paolo1ORCID, Russo Maria Giovanna1, Limongelli Giuseppe1
Affiliation:
1. Department of Translational Medical Sciences, Inherited and Rare Cardiovascular Diseases, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy 2. Directorate General of Health, Campania Region, 80131 Naples, Italy 3. Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy
Abstract
Introduction: The aim of this study was to evaluate the age at onset, clinical course, and patterns of left ventricular (LV) remodelling during follow-up in children and young patients with hypertrophic cardiomyopathy (HCM). Methods: We included consecutive patients with sarcomeric or non-syndromic HCM below 18 years old. Three pre-specified patterns of LV remodelling were assessed: maximal LV wall thickness (MLVWT) thickening; MLVWT thinning with preserved LV ejection fraction; and MLVWT thinning with progressive reduction in LV ejection fraction (hypokinetic end-stage evolution). Results: Fifty-three patients with sarcomeric/non-syndromic HCM (mean age 9.4 ± 5.5 years, 68% male) fulfilled the inclusion criteria. In total, 32 patients (60%) showed LV remodelling: 3 patients (6%) exhibited MLVWT thinning; 16 patients (30%) showed MLVWT thickening; and 13 patients (24%) progressed to hypokinetic end-stage HCM. Twenty-one patients (40%) had no LV remodelling during follow-up. In multivariate analysis, MLVWT was a predictor of the hypokinetic end-stage remodelling pattern during follow-up (OR 1.17 [95%CI 1.01–1.36] per 1 mm increase, p-value 0.043), regardless of sarcomeric variants and New York Heart Association class. Two patients with sarcomeric HCM, showing a pattern of MLVWT regression during childhood, experienced progression during adolescence. Conclusions: Different patterns of LV remodelling were observed in a cohort of children with sarcomeric/non-syndromic HCM. Interestingly, a pattern of progressive MLVWT thinning during childhood, with new progression of MLVWT during adolescence, was noted. A better understanding of the remodelling mechanisms in children with sarcomeric HCM may be relevant to defining the timing and possible efficacy of new targeted therapies in the preclinical stage of the disease.
Reference33 articles.
1. 2023 ESC Guidelines for the Management of Cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European So-ciety of Cardiology (ESC);Arbelo;Eur. Heart J.,2023 2. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement from the American Heart Association;Lipshultz;Circulation,2019 3. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review;Maron;J. Am. Coll. Cardiol.,2022 4. Mariani, M.V., Pierucci, N., Fanisio, F., Laviola, D., Silvetti, G., Piro, A., La Fazia, V.M., Chimenti, C., Rebecchi, M., and Drago, F. (2024). Inherited Arrhythmias in the Pediatric Population: An Updated Overview. Medicina, 60. 5. Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy;Musumeci;Am. J. Cardiol.,2018
|
|